Somatuline and tamoxifen in postmenopausal breast cancer patients.
Canobbio
L
L
Department of Medical Oncology II, National Institute for Cancer Research, Genova, Italy.
Cannata
D
D
Miglietta
L
L
Boccardo
F
F
D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010456:Peptides, Cyclic / Q000627:therapeutic use* / Q000633:toxicity*; D017698:Postmenopause; D013004:Somatostatin / Q000031:analogs & derivatives*; D013629:Tamoxifen / Q000627:therapeutic use* / Q000633:toxicity*
D010456:Peptides, Cyclic; D013629:Tamoxifen; C060347:lanreotide; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I